Home › Funds › WealthBridge Investment Counsel Inc. › GILD

WealthBridge Investment Counsel Inc. position in GILD

GILEAD SCIENCES INC · Health Care

WealthBridge Investment Counsel Inc. reported holding 63,605 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$9.5M, representing 2.52% of its reported portfolio and ranking #18 among its reported holdings. WealthBridge Investment Counsel Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.60K sh
Reported value held$9.48M
Portfolio Weight2.52%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How WealthBridge Investment Counsel Inc.'s GILD position evolved

WealthBridge Investment Counsel Inc. first disclosed a stake in GILD in Q3 2023 at 78,155 shares (US$5.9M). The position peaked in Q3 2026 at 63,605 shares, worth US$9.5M. Across 13 filings, WealthBridge Investment Counsel Inc. increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 63,605 shares valued at US$9.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.16K $5.86M New
Q4 2023 77.31K $6.26M Reduce
Q1 2024 74.06K $5.42M Reduce
Q2 2024 70.95K $4.87M Reduce
Q3 2024 70.61K $5.92M Hold
Q4 2024 70.20K $6.49M Reduce
Q1 2025 69.41K $7.78M Reduce
Q2 2025 64.95K $7.20M Reduce
Q3 2025 64.43K $7.15M Reduce
Q4 2025 64.33K $7.90M Hold
Q1 2026 63.80K $8.89M Reduce
Q2 2026 63.60K $8.04M Hold
Q3 2026 63.60K $9.48M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has WealthBridge Investment Counsel Inc. held GILD?

WealthBridge Investment Counsel Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WealthBridge Investment Counsel Inc.'s current position in GILD?

As of Q3 2026, WealthBridge Investment Counsel Inc. holds 63.60K shares of GILD (GILEAD SCIENCES INC), valued at $9.48M, representing 2.52% of its reported portfolio and ranking #18.

Has WealthBridge Investment Counsel Inc. been buying or selling GILD?

In the latest 13F filing (Q3 2026), WealthBridge Investment Counsel Inc. held unchanged its position in GILD. The position peaked in Q3 2026 at 63.60K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.